Small molecule hematopoietic growth factor mimetic compounds that activate hematopoietic growth factor receptors

US8680150B2 · kind B2 · utility

Assignee

• Ligand Pharmaceuticals Incorporated · US

Inventors

• Lin Zhi · San Diego, US
• Andrew R. Hudson · San Diego, US
• Cornelis Arjan Van Oeveren · Carlsbad, US
• Steven L. Roach · San Diego, US
• Jason C. Pickens · San Diego, US
• Yixing Shen · Encinitas, US
• Catalina Cuervo · San Diego, US
• Lino Valdez · Carlsbad, US
• Jillian Basinger · San Diego, US
• Virgina H. Grant · Vista, US

Key dates

• Filing date: May 6, 2010
• Grant date: Mar 25, 2014
• Expiry date: Oct 29, 2030

Classification

• Technology area (CPC G): Physics
• CPC primary: G01N2500/10
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

The present embodiments relate to compounds with physiological effects, such as the activation of hematopoietic growth factor receptors. The present embodiments also relate to use of the compounds to treat a variety of conditions, diseases and ailments such as hematopoietic conditions and disorders.